374 related articles for article (PubMed ID: 3973011)
1. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
Wang CS; McConathy WJ; Kloer HU; Alaupovic P
J Clin Invest; 1985 Feb; 75(2):384-90. PubMed ID: 3973011
[TBL] [Abstract][Full Text] [Related]
2. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T
Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148
[TBL] [Abstract][Full Text] [Related]
3. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism.
Shirai K; Fitzharris TJ; Shinomiya M; Muntz HG; Harmony JA; Jackson RL; Quinn DM
J Lipid Res; 1983 Jun; 24(6):721-30. PubMed ID: 6688442
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III.
McConathy WJ; Gesquiere JC; Bass H; Tartar A; Fruchart JC; Wang CS
J Lipid Res; 1992 Jul; 33(7):995-1003. PubMed ID: 1431591
[TBL] [Abstract][Full Text] [Related]
7. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
8. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
[TBL] [Abstract][Full Text] [Related]
10. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL.
Berbée JF; van der Hoogt CC; Sundararaman D; Havekes LM; Rensen PC
J Lipid Res; 2005 Feb; 46(2):297-306. PubMed ID: 15576844
[TBL] [Abstract][Full Text] [Related]
11. Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia.
Stalenhoef AF; Casparie AF; Demacker PN; Stouten JT; Lutterman JA; van 't Laar A
Metabolism; 1981 Sep; 30(9):919-26. PubMed ID: 7266379
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
[TBL] [Abstract][Full Text] [Related]
13. Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.
Larsson M; Vorrsjö E; Talmud P; Lookene A; Olivecrona G
J Biol Chem; 2013 Nov; 288(47):33997-34008. PubMed ID: 24121499
[TBL] [Abstract][Full Text] [Related]
14. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
Amar MJ; Sakurai T; Sakurai-Ikuta A; Sviridov D; Freeman L; Ahsan L; Remaley AT
J Pharmacol Exp Ther; 2015 Feb; 352(2):227-35. PubMed ID: 25395590
[TBL] [Abstract][Full Text] [Related]
15. Effects of apolipoprotein C-II (apoC-II) on the lipolysis of very low density lipoproteins from apoC-II deficient patients.
Matsuoka N; Shirai K; Johnson JD; Kashyap ML; Srivastava LS; Yamamura T; Yamamoto A; Saito Y; Kumagai A; Jackson RL
Metabolism; 1981 Aug; 30(8):818-24. PubMed ID: 6894960
[No Abstract] [Full Text] [Related]
16. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
17. Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation.
Silbernagel G; Chen YQ; Rief M; Kleber ME; Hoffmann MM; Stojakovic T; Stang A; Sarzynski MA; Bouchard C; März W; Qian YW; Scharnagl H; Konrad RJ
Eur Heart J; 2023 Jul; 44(25):2335-2345. PubMed ID: 37155355
[TBL] [Abstract][Full Text] [Related]
18. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
[TBL] [Abstract][Full Text] [Related]
19. Effect of human high density lipoproteins, anti-apolipoproteins CII and CIII, and hydrolysis of very low density lipoprotein (VLDL) cholesterol ester on VLDL catabolism in vitro.
Liu BW; Hynd BA; Kashyap ML
Biochem Biophys Res Commun; 1984 Jun; 121(3):946-52. PubMed ID: 6588972
[TBL] [Abstract][Full Text] [Related]
20. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
van Barlingen HH; Kock LA; de Man FH; Erkelens DW; de Bruin TW
Atherosclerosis; 1996 Mar; 121(1):75-84. PubMed ID: 8678926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
